PDCD1LG2 and neoplasm: The extrinsic pathway relies on the release of inflammatory signals (i.e., IFN-γ) by TILs after tumor antigen recognition, consequently upregulating the expression of PD-L1/PD-L2 in tumor cells and TME cells [121].